Key Takeaways
- A civil investigation into Lululemon was initiated by Texas AG Ken Paxton on April 13, 2026
- The probe examines potential presence of PFAS chemicals, known as “forever chemicals,” in the company’s products
- Shares of LULU fell more than 3% following the announcement
- Investigators will scrutinize the company’s Restricted Substances List, quality testing procedures, and supplier practices
- This legal challenge compounds existing difficulties including weakening revenue and leadership changes
On Monday, Texas Attorney General Ken Paxton delivered a Civil Investigative Demand to Lululemon, triggering a stock decline exceeding 3%.
Lululemon Athletica Inc., LULU
The inquiry centers on allegations that the athletic apparel retailer may have deceived customers regarding the health and safety attributes of its merchandise.
Central to this investigation is the question of whether Lululemon’s garments contain PFAS — dubbed “forever chemicals” — substances consumers wouldn’t anticipate based on the company’s marketing messaging.
These PFAS compounds have been associated with hormonal disruption, reproductive issues, and various cancers.
“Americans should not have to worry if they are being deceived when trying to make healthy choices for themselves and their families,” Paxton stated in his official announcement. “I will not allow any corporation to sell harmful, toxic materials to consumers at a premium price under the guise of wellness and sustainability.”
The statement carries significant weight. Given that Lululemon has constructed its brand identity largely around wellness principles and environmental responsibility, this investigation directly challenges the company’s fundamental positioning.
Scope of the Investigation
Investigators from the Texas AG’s office intend to examine Lululemon’s Restricted Substances List, evaluate its product testing methodologies, and analyze its supplier oversight procedures.
The investigation aims to verify whether the company’s merchandise genuinely meets the safety benchmarks it publicly claims to uphold.
For fiscal year 2025, Lululemon reported revenues exceeding $11 billion, positioning itself as an upscale, wellness-focused lifestyle company.
Additional Challenges Mount for LULU
This legal scrutiny arrives during a particularly challenging period for the athletic apparel maker.
Lululemon has been grappling with weakening sales performance and declining stock valuations as 2026 unfolds.
The organization is simultaneously navigating a change in chief executive leadership while managing demands from an activist shareholder.
Adding to these pressures, Chip Wilson, who founded the company, has been openly advocating for board composition changes.
The Texas investigation represents another obstacle in an expanding series of challenges facing the retailer.
Analyst sentiment on LULU currently stands at Hold, reflecting the consensus of 20 analysts who issued ratings within the past three months. The breakdown includes one Buy rating alongside 19 Hold recommendations.
The mean price target stands at $179.53, suggesting potential upside of approximately 11.5% from present trading levels.


